Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-6.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -17.32% |
| Q3 2025 | 19.66% |
| Q2 2025 | 5.68% |
| Q1 2025 | 49.78% |
| Q4 2024 | 4.37% |
| Q3 2024 | 2.74% |
| Q2 2024 | -14.18% |
| Q1 2024 | 4.35% |
| Q4 2023 | -33.30% |
| Q3 2023 | -13.50% |
| Q2 2023 | 4.72% |
| Q1 2023 | -17.28% |
| Q4 2022 | 5.03% |
| Q3 2022 | -5.11% |
| Q2 2022 | -21.10% |
| Q1 2022 | -3.66% |
| Q4 2021 | -1.78% |
| Q3 2021 | 3.47% |
| Q2 2021 | 5.20% |
| Q1 2021 | -67.38% |
| Q4 2020 | 2.82% |
| Q3 2020 | -7.94% |
| Q2 2020 | 8.50% |
| Q1 2020 | -16.96% |
| Q4 2019 | 14.61% |
| Q3 2019 | -23.86% |
| Q2 2019 | 11.83% |
| Q1 2019 | 6.56% |
| Q4 2018 | -25.82% |
| Q3 2018 | -6.28% |
| Q2 2018 | 15.89% |
| Q1 2018 | 15.53% |
| Q4 2017 | -17.36% |
| Q3 2017 | -8.31% |
| Q2 2017 | -14.37% |
| Q1 2017 | -6.19% |
| Q4 2016 | -7.31% |
| Q3 2016 | -5.79% |
| Q2 2016 | -16.60% |
| Q1 2016 | -11.97% |